Universal Health Services Inc (UHS) stock
Close on Oct 30, 2026Market cap $10.38BP/E 7.2Yield 0.45%
Earnings
Universal Health Services's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Universal Health Services's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 27, 2026after the close | $4.73B | +5.3% | $5.22 | $5.22 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 28, 2026before the open | $4.64B | +8.3% | $5.98 | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 28, 2026before the open | $4.50B | +9.6% | $5.65 | $5.62 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026before the open | $4.49B | +9.0% | $7.06 | $5.88 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025before the open | $4.50B | +13.4% | $5.86 | $5.69 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025before the open | $4.28B | +9.6% | $5.43 | $5.35 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 29, 2025before the open | $4.10B | +6.7% | $4.80 | $4.84 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025before the open | $4.11B | +11.1% | $4.96 | $4.92 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 25, 2024before the open | $3.96B | +11.2% | $3.80 | $3.71 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024before the open | $3.91B | +10.1% | $4.26 | $4.31 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024before the open | $3.84B | +10.8% | $3.82 | $3.70 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024after the close | $3.70B | +7.5% | $3.16 | $3.13 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023before the open | $3.56B | +6.8% | $2.40 | $2.55 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 26, 2023before the open | $3.55B | +6.8% | $2.42 | $2.53 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 26, 2023before the open | $3.47B | +5.3% | $2.28 | $2.34 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 27, 2023after the close | $3.45B | +5.3% | $2.43 | $3.02 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 25, 2022after the close | $3.34B | +5.7% | $2.50 | $2.54 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022before the open | $3.32B | – | $2.20 | $2.20 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 26, 2022before the open | $3.29B | – | $2.02 | $2.15 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022after the close | $3.28B | – | $3.00 | $2.95 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 26, 2021before the open | $3.16B | – | $2.60 | $2.67 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 27, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021after the close | – | – | – | – | Release |
| Q3 FY2020ended Sep 30, 2020 | Oct 30, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Universal Health Services's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net revenues | FY2026 | $18.50B – $18.76B | $18.42B – $18.79B | Narrowed | Jul 28, 2026 |
| Adjusted EBITDA, net of NCInon-GAAP | FY2026 | $2.61B – $2.72B | $2.64B – $2.79B | Lowered | Jul 28, 2026 |
| Adjusted EPS – dilutednon-GAAP | FY2026 | $22.28 – $23.65 | $22.64 – $24.52 | Lowered | Jul 28, 2026 |
| capital expenditures | FY2026 | $950.00M – $1.10M | $950.00M – $1.10M | Reaffirmed | Jul 28, 2026 |
Guidance vs results
The last range Universal Health Services gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted EPS – diluted | $21.50 – $22.10 | $21.76Σ4Q | Within range |
| FY2025 | Revenue | $17.31B – $17.45B | $17.37BΣ4Q | Within range |
Guidance history
Every forecast Universal Health Services put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Jul 28, 2026 | capital expenditures | FY2026 | $950.00M – $1.10M | Reaffirmed |
| Jul 28, 2026 | Adjusted EBITDA, net of NCI | FY2026 | $2.61B – $2.72B | Lowered |
| Jul 28, 2026 | Adjusted EPS – diluted | FY2026 | $22.28 – $23.65 | Lowered |
| Jul 28, 2026 | Net revenues | FY2026 | $18.50B – $18.76B | Narrowed |
| Feb 26, 2026 | Capital expenditures | FY2026 | $950.00M – $1.10M | New |
| Feb 26, 2026 | Adjusted EBITDA net of NCI | FY2026 | $2.64B – $2.79B | New |
| Feb 26, 2026 | EPS-diluted | FY2026 | $22.64 – $24.52 | New |
| Feb 26, 2026 | Net revenues | FY2026 | $18.42B – $18.79B | New |
| Oct 28, 2025 | Adjusted EBITDA, net of NCI | FY2025 | $2.57B – $2.62B | New |
| Oct 28, 2025 | Adjusted EPS – diluted | FY2025 | $21.50 – $22.10 | New |
| Oct 28, 2025 | Net revenues | FY2025 | $17.31B – $17.45B | New |
| Jul 29, 2025 | Adjusted EBITDA, net of NCI | FY2025 | $2.46B – $2.54B | Raised |
| Jul 29, 2025 | Adjusted EPS-diluted | FY2025 | $20.00 – $21.00 | Raised |
| Jul 29, 2025 | Net revenues | FY2025 | $17.10B – $17.31B | Narrowed |
| Feb 27, 2025 | Adjusted EBITDA net of NCI increase | FY2025 | +4.9% – +10.6% | New |
| Feb 27, 2025 | Adjusted EBITDA net of NCI | FY2025 | $2.36B – $2.48B | New |
| Feb 27, 2025 | EPS-diluted increase | FY2025 | +11.1% – +20.1% | New |
| Feb 27, 2025 | EPS-diluted | FY2025 | $18.45 – $19.95 | New |
| Feb 27, 2025 | net revenues increase | FY2025 | +7.5% – +9.7% | New |
| Feb 27, 2025 | Net revenues | FY2025 | $17.02B – $17.36B | New |
| Jul 25, 2024 | Adjusted EBITDA, net of NCI | FY2024 | $2.15B – $2.23B | Raised |
| Jul 25, 2024 | Adjusted EPS-diluted | FY2024 | $15.40 – $16.20 | Raised |
| Jul 25, 2024 | net revenues | FY2024 | $15.57B – $15.75B | Raised |
| Feb 27, 2024 | Adjusted EBITDA net of NCI | FY2024 | $1.93B – $2.02B | New |
| Feb 27, 2024 | EPS-diluted range | FY2024 | $13.00 – $14.00 | New |
| Feb 27, 2024 | net revenues | FY2024 | $15.41B – $15.71B | New |
| Jul 26, 2023 | Adjusted EBITDA, net of NCI | FY2023 | $1.70B – $1.76B | Raised |
| Jul 26, 2023 | Adjusted EPS – diluted | FY2023 | $9.85 – $10.50 | Raised |
| Jul 26, 2023 | Net revenues | FY2023 | $14.13B – $14.33B | Raised |
| Feb 27, 2023 | Adjusted EBITDA net of NCI | FY2023 | $1.66B – $1.75B | New |
| Feb 27, 2023 | Adjusted EPS-diluted | FY2023 | $9.50 – $10.50 | New |
| Feb 27, 2023 | net revenues | FY2023 | $14.04B – $14.31B | New |
| Feb 24, 2022 | Adjusted EBITDA net of NCI | FY2022 | $1.83B – $1.93B | New |
| Feb 24, 2022 | Adjusted EPS-diluted | FY2022 | $11.90 – $12.90 | New |
| Feb 24, 2022 | net revenues | FY2022 | $13.42B – $13.69B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Universal Health Services filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results